Votrient (pazopanib hydrochloride)

pCPA File Number: 20771
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Renal Cell Carcinoma
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
PC0022-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: